Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 741 Records) |
Query Trace: Carcinoma and EGFR[original query] |
---|
Prognostic Significance of Volumetric Parameters Based on FDG PET/CT in Patients with Lung Adenocarcinoma Undergoing Curative Surgery. Cancers 2023 9 15 (17): . Hyunjong Lee, Yoon-La Choi, Hong Kwan Kim, Yong Soo Choi, Hojoong Kim, Myung-Ju Ahn, Hong Ryul Pyo, Joon Young Ch |
A Prospective Cohort Study Assessing the Relationship between Plasma Levels of Osimertinib and Treatment Efficacy and Safety. Biomedicines 2023 9 11 (9): . Tatsuro Fukuhara, Kazuhiro Imai, Taku Nakagawa, Ryotaro Igusa, Hayato Yokota, Kana Watanabe, Aya Suzuki, Mami Morita, Ren Onodera, Akira Inoue, Masatomo Miura, Yoshihiro Minamiya, Makoto Maemon |
Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas. Human pathology 2023 9 . Haiyue Wang, Linghua Yan, Yanli Zhu, Wei Sun, Xin Yang, Xinying Liu, Kaiwen Chi, Xiaozheng Huang, Lixin Zhou, Dongmei L |
The Association of Epidermal Growth Factor Variant with Oral Squamous Cell Carcinoma. Environmental and molecular mutagenesis 2023 9 . Baris Ertugrul, Amal Mohammad, Goksu Kasarci, Sinem Bireller, Murat Ulusan, Bedia Cakmakog |
Association of PD-L1 tumor proportion score ?20% with early resistance to osimertinib in patients with EGFR-mutated NSCLC. Cancer medicine 2023 8 . Yusuke Hamakawa, Yoko Agemi, Aya Shiba, Toshiki Ikeda, Yuko Higashi, Masaharu Aga, Kazuhito Miyazaki, Yuri Taniguchi, Yuki Misumi, Yukiko Nakamura, Tsuneo Shimokawa, Yusuke Saigusa, Nobuaki Kobayashi, Hiroaki Okamoto, Takeshi Kane |
Efficacy of osimertinib for lung squamous cell carcinoma with de novo EGFR T790M-positive: Case report and literature review. Thoracic cancer 2023 8 . Chihiro Maeda, Kanako Shinada, Shuji Murakami, Haruhiro Sai |
Transformation of Lung Squamous Cell Carcinoma to Small Cell Lung Cancer After Immunotherapy Resistance: A Case Report. Cancer management and research 2023 8 15 803-808. Diming Wang, Wei Ye, Dongmei Chen, Qingming Shi, Dongchun |
Real-world challenges in undertaking NTRK fusion testing in non-small cell lung cancer. Journal of thoracic disease 2023 8 15 (7): 3811-3817. Ashleigh Poh, Abdelaziz Sammour, Jared Mathai, Joanne Peverall, Chris Van Vliet, Khashayar Asadi, Sagun Para |
Durable response of lung carcinoma patients to EGFR tyrosine kinase inhibitors is determined by germline polymorphisms in some immune-related genes. Molecular cancer 2023 7 22 (1): 120. Lorraine Dalens, Julie Niogret, Corentin Richard, Sandy Chevrier, Pascal Foucher, Bruno Coudert, Aurélie Lagrange, Laure Favier, Virginie Westeel, Stefano Kim, Olivier Adotevi, Caroline Chapusot, Laurent Martin, Laurent Arnould, Courèche-Guillaume Kaderbhai, Romain Boid |
Gene mutation profiling and clinical significances in patients with renal cell carcinoma. Clinics (Sao Paulo, Brazil) 2023 7 78 100259. Yongquan Wang, Peng He, Xiaozhou Zhou, Cong Wang, Jian Fu, Dawei Zhang, Deyang Liao, Zhansong Zhou, Chunman Wu, Wei Go |
Genetic characteristics of advanced oral tongue squamous cell carcinoma in young patients. Oral oncology 2023 7 144 106466. Sehui Kim, Chung Lee, Hyangmi Kim, Sun Och Yo |
Genetic Polymorphisms of ACE1 Rs4646994 Associated with Lung Cancer in Patients with Pulmonary Nodules: A Case-Control Study. Biomedicines 2023 6 11 (6): . Rong Qiao, Siyao Sang, Jiajun Teng, Hua Zhong, Hui Li, Baohui H |
Association Between 18F-Fluorodeoxyglucose Uptake and Mutation Status of Epidermal Growth Factor Receptor in Sinonasal Tract Cancer. Anticancer research 2023 6 43 (7): 3247-3253. Hidenori Suzuki, Eiichi Sasaki, Tsuneo Tamaki, Takeshi Kodaira, Masami Nishio, Daisuke Nishikawa, Shintaro Beppu, Hoshino Terada, Michi Sawabe, Nobuhiro Han |
Identify the Clinicopathological Characteristics of Lung Carcinoma Patients Being False Negative in Folate Receptor Based Circulating Tumor Cell Detection. Small methods 2023 6 e2300055. Siming Jiang, Hao Wang, Junjie Zhu, Xinnan Xu, Linsong Chen, Bo Wang, Bin Zhou, Yuming Zhu, Zhemin Zhang, Benting Ma, Bin Du, Yang Ya |
Brain-Tumor Interface-Based MRI Radiomics Models to Determine EGFR Mutation, Response to EGFR-TKI and T790M Resistance Mutation in Non-Small Cell Lung Carcinoma Brain Metastasis. Journal of magnetic resonance imaging : JMRI 2023 5 . Ying Fan, Xinti Wang, Chunna Yang, Huanhuan Chen, Huan Wang, Xiaoyu Wang, Shaoping Hou, Lihua Wang, Yahong Luo, Xianzheng Sha, Huazhe Yang, Tao Yu, Xiran Jia |
Utilisation Patterns and Treatment Outcomes of EGFR-Tyrosine Kinase Inhibitors in EGFR-mutant Advanced Lung Carcinoma in the Pakistani-Asian Population: A Real-world Data Study. Journal of cancer & allied specialties 2023 5 9 (1): 491. Kiran Munawar, Romena Qazi, Hassan Shahryar Shei |
Genomic profiling of NGS-based ctDNA from Chinese non-small cell lung cancer patients. Journal of cancer research and clinical oncology 2023 5 . Yanfeng Xi, Zhongyuan Bai, Sihang Gao, Jianghong Guo, Zhen Zhang, Hongling Zhang, Li Qu, Bing Xu, Weiwei Wang, Guangyu Shan, Wei Cui, Wenqi Bai, Xiaoyong |
Whole-exome and targeted gene sequencing of large-cell lung carcinoma reveals recurrent mutations in the PI3K pathway. British journal of cancer 2023 5 . Jun-Hong Guo, Yu-Shui Ma, Jie-Wei Lin, Geng-Xi Jiang, Juan He, Hai-Min Lu, Wei Wu, Xun Diao, Qi-Yu Fan, Chun-Yan Wu, Ji-Bin Liu, Da Fu, Li-Kun H |
Human Papillomavirus Infection and EGFR Exon 20 Insertions in Sinonasal Inverted Papilloma and Squamous Cell Carcinoma. Journal of personalized medicine 2023 4 13 (4): . Hitoshi Hirakawa, Taro Ikegami, Norimoto Kise, Hidetoshi Kinjyo, Shunsuke Kondo, Shinya Agena, Narumi Hasegawa, Junko Kawakami, Hiroyuki Maeda, Mikio Suzu |
Differences in Pleural Fluid Amylase Levels in Patients with Malignant Pleural Effusion Based on Cancer Type, Histologic Type, and Epidermal Growth Factor Receptor Mutations. Internal medicine (Tokyo, Japan) 2023 4 . Masafumi Shimoda, Yoshiaki Tanaka, Kozo Morimoto, Kozo Yoshimori, Ken Oh |
Survival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world study. Frontiers in oncology 2023 3 13 1113696. Gow Chien-Hung, Hsieh Min-Shu, Chen Yi-Lin, Liu Yi-Nan, Wu Shang-Gin, Shih Jin-Yu |
Clinicopathological characteristics and molecular analysis of lung cancer associated with ciliated muconodular papillary tumor/bronchiolar adenoma. Pathology international 2023 3 . Higashiyama Masahiro, Motoi Noriko, Yotsukura Masaya, Yoshida Yukihiro, Nakagawa Kazuo, Yagishita Shigehiro, Shirasawa Masayuki, Yoshida Tatsuya, Shiraishi Kouya, Kohno Takashi, Ohe Yuichiro, Watanabe Shun-Ic |
The Prognostic Value and the Oncogenic and Immunological Roles of Vacuolar Protein Sorting Associated Protein 26 A in Pancreatic Adenocarcinoma. International journal of molecular sciences 2023 2 24 (4): . Hou Jihuan, Wu Han, Xu Beibei, Shang Jin, Xu Xuechun, Li Guixia, Zhang Haoran, Zhang Wenqing, Deng Yabin, Hong Xiaoting, Hu Tianhui, Zhang Mingqing, Zhan Yany |
ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing. Gynecologic oncology 2023 2 171 59-66. Machida Hiroko, Matsuo Koji, Tanaka Masayuki, Kitatani Kanae, Takase Akinori, Yokoyama Keiko, Kajiwara Hiroshi, Yasaka Miwa, Ikeda Masae, Yoshida Hiroshi, Hirasawa Takeshi, Mikami Mik |
EGFR Mutation in Non-squamous Non-small-cell Lung Carcinoma (NS-NSCLC) in the Arab World: A systematic Review. The Gulf journal of oncology 2023 2 1 (41): 54-61. Nassar Dany, Chidiac Claudia, Ibrahim Elio, Abou Zeid Karl, Haddad Fady, Kourie Hamp |
Clinicogenomic Landscape of Metastatic Thymic Epithelial Tumors. JCO precision oncology 2023 2 7 e2200465. Ardeshir-Larijani Fatemeh, Schneider Bryan P, Althouse Sandra K, Radovich Milan, Masood Ashiq, Perna Fabiana, Salman Huda, Loehrer Patrick |
PDL1 and molecular biomarkers expression in non-small cell lung cancer in Tunisian patients. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2023 11 . Yoldez Houcine, Chirine Moussa, Ahmed Ben Abdelaziz, Aida Aya |
DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients. Diagnostic pathology 2023 11 18 (1): 119. Weiguang Gu, Wenya Zhuang, Mengxia Zhuang, Minhong He, Zhihua |
Molecular study of colorectal carcinoma and EGFR gene mutations. Cellular and molecular biology (Noisy-le-Grand, France) 2023 10 69 (9): 177-182. Shayan Rasheed Abubakir, Hazha Jamal Hiday |
Correlation Analysis of the TP53 Mutation With Clinical Characteristics in the Prognosis of Non-Small Cell Lung Cancer. Clinical Medicine Insights. Oncology 2023 10 17 11795549231184918. Lihuan Zhu, Dongsheng Zhou, Yiyong Chen, Tianxing Guo, Wenshu Chen, Xiaojie P |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 04, 2023
- Content source: